Pfizer Q1 Results: Net Profit Jumps 7%, Revenue Marginally Increases To Rs 653 Crore

Pfizer Q1 Results: 

Pharmaceutical major Pfizer has reported a steady financial performance for the first quarter, posting a 6.6% year-on-year (YoY) increase in net profit. The company's bottom line grew to ₹205 crore, up from ₹192 crore in the corresponding quarter of the previous fiscal year, driven by healthy operational metrics and consistent top-line growth.

Revenue for the quarter climbed 8.3% YoY to ₹653 crore, compared to ₹603 crore reported in the same period last year. The growth highlights the company's resilient sales performance across its core pharmaceutical portfolios.

Key Financial Highlights
Here is a breakdown of Pfizer's Q1 performance:

Net Profit: Grew 6.6% YoY to ₹205 crore (vs. ₹192 crore).

Revenue: Rose 8.3% YoY to ₹653 crore (vs. ₹603 crore).

EBITDA: Jumped 17.9% YoY to ₹248 crore (vs. ₹210 crore).

EBITDA Margin: Expanded by 310 basis points to 37.9% (vs. 34.8%).

Other Income: Declined to ₹44.8 crore (vs. ₹67.2 crore).

Operational Efficiency Drives Margin Expansion
The standout metric for the quarter was the company's operational efficiency. Pfizer saw a robust 17.9% surge in its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA), which came in at ₹248 crore.

This strong operational execution resulted in a significant expansion in profitability. The EBITDA margin expanded by 310 basis points to reach 37.9%, up from 34.8% in the year-ago period.

However, the overall net profit growth was slightly moderated by a sharp drop in other income, which fell to ₹44.8 crore during the quarter, compared to ₹67.2 crore in the same period last year. Despite this drag, the core business strength and improved margin profile kept the quarterly results in positive territory.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.